catalog number :
MBS476569
products full name :
Anti-RELB Mouse mAb
products short name :
[RELB]
products name syn :
[IREL; I-REL; REL-B]
other names :
[RelB (plasmid); Transcription factor RelB; transcription factor RelB; RELB proto-oncogene, NF-kB subunit; I-Rel]
products gene name :
[RELB]
products gene name syn :
[IREL; I-REL; REL-B]
other gene names :
[RELB; RELB; IREL; I-REL; REL-B]
form :
Purified antibody in PBS with 0.05% sodium azide.
tested application :
Western Blot (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Flow Cytometry (FC/FACS)
image1 heading :
Western Blot (WB)
image2 heading :
Western Blot (WB)
image3 heading :
Immunofluorescence (IF)
image4 heading :
Flow Cytometry (FC/FACS)
image4 description :
Flow cytometric analysis of MCF-7 cells using RELB mouse mAb (green) and negative control (red).
image5 heading :
Immunohistochemistry (IHC)
image5 description :
Immunohistochemical analysis of paraffin-embedded cervical cancer tissues using RELB mouse mAb with DAB staining.
other info1 :
Immunogen: Purified recombinant fragment of human RELB (AA: 273-443) expressed in E Coli. Conjugation: Unconjugated
other info2 :
Subcellular location: Cytoplasm, Cytoskeleton, Nucleus.
products description :
Entrez Summary: NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. RELB neither associates with DNA nor with RELA/p65 or REL. Stimulates promoter activity in the presence of NFKB2/p49. As a member of the NUPR1/RELB/IER3 survival pathway, may provide pancreatic ductal adenocarcinoma with remarkable resistance to cell stress, such as starvation or gemcitabine treatment
ncbi acc num :
AJS10497.1
ncbi pathways :
Alternative NF-kappaB Pathway (138004); C-type Lectin Receptors (CLRs) Pathway (1269303); CD209 (DC-SIGN) Signaling Pathway (1269309); CLEC7A (Dectin-1) Signaling Pathway (1269304); Circadian Rythm Related Genes Pathway (1458220); Cytokine Signaling In Immune System Pathway (1269310); Dectin-1 Mediated Noncanonical NF-kB Signaling Pathway (1269306); Epstein-Barr Virus Infection Pathway (585562); Epstein-Barr Virus Infection Pathway (587115); HTLV-I Infection Pathway (373901)
uniprot summary :
RELB: a transcription factor of the nuclear factor-kappaB (NFkB) transcription complex. Stimulates promoter activity in the presence NFkB1/NFkB-p50. Plays role in regulation of apoptosis in hepatocellular carcinoma through activation of downstream target genes. Does not associate with DNA or RelA/NFkB-p65. Protein type: Transcription factor. Chromosomal Location of Human Ortholog: 19q13.32. Cellular Component: cytoplasm; cytosol; nucleoplasm; nucleus. Molecular Function: chromatin binding; protein binding; transcription corepressor activity; transcription factor activity. Biological Process: circadian regulation of gene expression; I-kappaB kinase/NF-kappaB cascade; inflammatory response; innate immune response; negative regulation of interferon-beta production; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; response to cytokine stimulus; stimulatory C-type lectin receptor signaling pathway